MEPs seek SEP policy changes; EPO invalidates Moderna mRNA patent; patent pool royalty sharing; Panasonic interview; secondary patent market data; plus much more

MEPs seek SEP policy changes; EPO invalidates Moderna mRNA patent; patent pool royalty sharing; Panasonic interview; secondary patent market data; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week.

MONDAY 20 November

Radical SEP regulation amendments sought by several European Parliament groups

Data dive: Trade secret complaints at the US International Trade Commission

TUESDAY 21 November

Interview: Biocon Biologics eyes expanding biosimilars litigation campaign

Trade secrets: Versata v Ford saga brings reverse engineering risks to the fore

Key Moderna mRNA patent invalidated by EPO

WEDNESDAY 22 November

Royalty sharing in SEP patent pools – how the sausage gets made

Nokia uses UPC and Munich court to turn up the pressure on Hewlett-Packard

Long read: Coming to America – funding for small innovators seeking patents to enter the US

THURSDAY 23 November

Weekly column: The IP world is kidding itself if it thinks it’s winning

Event coverage: Eligibility and PTAB reform bills spark debate

Data dive: Europe's top 100 patent owners for 2022

FRIDAY 24 November

Interview: Asian companies should be ‘more vocal’ in global IP discussions, says Panasonic’s chief IP counsel

Will genAI on smartphones boost cellular SEP royalty revenue?

Data dive: Software, electronics and semiconductors most transacted assets in Q3 2023

SATURDAY 25 November

Opinion: China’s image as an IP powerhouse should be seen as a business opportunity, not a threat

Unlock unlimited access to all IAM content